Abiopharma

🔍 Christiansen Jason Paul (Executive)

Company: Weave Communications, Inc. (WEAV)

Report Date: 2026-03-26

Detailed Transactions and Holdings:

• Acquired 300,000 shares of Common Stock (Direct)
  Date: 2026-03-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 761,399.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents shares of Common Stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest as to 33% of the total number of shares on March 1, 2027, and the remainder in equal quarterly installments over the two years thereafter, until such time as the RSU is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
• F2: Includes 2,500 shares acquired under the Issuer's employee stock purchase plan (the "ESPP") on February 25, 2026. The acquisition of these shares under the ESPP is exempt under Rule 16b-3(c).
• F3: Includes a correction of an administrative error as a result of which we reported 4,006 shares withheld when it was acutally 4,585 shares withheld by the Issuer to satisfy tax obligations relating to the acquisition of shares of the Issuer's Common Stock in connection with the settlement of the vested portion of restricted stock units.